Brief: Prostatype Genomics Q4 EBITDA Loss Widens To SEK 5.7 Mln

Prostatype Genomics AB

24/02/2022 07:18

Feb 24 (Reuters) - Prostatype Genomics AB  PROGEN.ST :
    * Q4 NET SALES AMOUNTED TO 0 (347) TSEK.
    * Q4 EBITDA (EARNINGS BEFORE INTEREST, TAXES, DEPRECIATION,
AND
AMORTIZATION) AMOUNTED TO -5 712 (-4 731) TSEK.

Source text for Eikon:  ID:nWkr66zCv1 
Further company coverage:  PROGEN.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))